NORTHCOTT JOHN
SEC CIK 1615000 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | SVP, Chief Commercial Off | 223.2K | — | $236.7K | 5 | 2021-08-16 | 2022-05-16 |
Most active insiders at NKTR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBIN HOWARD W | Pres, CEO, Dir | — | $1.42M |
| 2 | Zalevsky Jonathan | Chief R, D Off | — | $974.2K |
| 3 | Wilson Mark Andrew | CLO | — | $34.2K |
NORTHCOTT JOHN made no open-market trades at NKTR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-17 | 2022-05-16 | NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP, Chief Commercial Off | S - Sale | $3.95 | -4,592 | 223.2K | -2% | -$18.1K | |
| 2022-02-18 | 2022-02-16 | NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP, Chief Commercial Off | S - Sale | $10.95 | -4,852 | 227.8K | -2% | -$53.1K | |
| D | 2021-12-20 | 2021-12-16 | NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP, Chief Commercial Off | A - Grant | $0.00 | +37.8K | 232.7K | +19% | $0 |
| 2021-11-17 | 2021-11-16 | NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP, Chief Commercial Off | S - Sale | $13.16 | -6,061 | 194.9K | -3% | -$79.8K | |
| 2021-08-18 | 2021-08-16 | NKTR | NEKTAR THERAPEUTICS | NORTHCOTT JOHN | SVP, Chief Commercial Off | S - Sale | $13.83 | -6,192 | 200.9K | -3% | -$85.6K |
Purchase Sale Sale after option exercise All abbreviations